FREDERICK, Md., Aug. 27, 2015 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that three abstracts featuring the use of ActiPatch®, its novel musculoskeletal pain therapy, will be presented at the 9th Congress of the European Pain Federation EFIC®, Vienna, Austria, 2-5th September 2015. The Company will also be exhibiting at the Congress in booth 09A.
Dr Gianluca Bagnato, department clinical and experimental rheumatology from the University of Messina, Italy will present his study on BioElectronics ActiPatch®, Musculoskeletal Pain Therapy device Pulsed electromagnetic fields in knee osteoarthritis: A double blind, placebo-controlled, randomized clinical trial on the 3rd of September.
BioElectronics Director of Clinical Research, Ian M. Rawe, PhD, and Executive Vice President, Deepak C Kotak MA, MBBS, FRCA, MRCP, LLM and will present two abstracts: Self-Management of severe arthritis pain with a novel over the counter device and Non-Invasive neuromodulation for severe chronic back pain: A UK registry study of pulsed shortwave therapy, http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 on the 5th September.
The 9th Congress of the European Pain Federation http://efic.kenes.com will focus on current trends and future developments in pain medicine. The conference of 36 European National Pain Societies consist of 20,000 healthcare professionals, researchers, and regulatory managers, who study pain, treat patients, or establish treatment policies for pain sufferers.
BioElectronics has taken PSWT (pulsed shortwave therapy) a proven therapy miniaturized the device, lowered the power level and honed the signal to provide low cost superior 24-hour extended duration relief. The devices provide 720-hours of flexible on/off therapy for under $30.00 retail, or $0.04 per hour. The devices are available over the counter at Walgreens Boots and other European pharmacies.
About BioElectronics Corporation
BioElectronics Corporation is a leader in Bioelectroceutical devices and the maker of an industry leading family of disposable, drug-free, anti-inflammatory devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; HealFast® Therapy for veterinary applications, Allay® Menstrual Pain Therapy and Smart Insole™ Heel Pain Therapy. Visit www.bielcorp.com for more information.
BioElectronics Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bioelectronics-selected-to-present-its-pain-research-and-devices-at-the-european-pain-federation-conference-300133714.html
SOURCE BioElectronics Corporation